Robert Seifert | IKIM MMLhttps://mml.kite.ume.de/authors/robert-seifert/Robert SeifertHugoBlox Kit (https://hugoblox.com)en-usSun, 01 Jan 2023 00:00:00 +0000Evaluation of thresholding methods for the quantifcation of 68Ga‑PSMA‑11 PET molecular tumor volume and their efect on survival prediction in patients with advanced prostate cancer undergoing 177Lu‑PSMA‑617 radioligand therapyhttps://mml.kite.ume.de/publications/kim-evaluation-2023/Sun, 01 Jan 2023 00:00:00 +0000https://mml.kite.ume.de/publications/kim-evaluation-2023/Artificial intelligence guided enhancement of digital PET: scans as fast as CT?https://mml.kite.ume.de/publications/hosch-artificial-2022/Fri, 01 Jul 2022 00:00:00 +0000https://mml.kite.ume.de/publications/hosch-artificial-2022/Vesseg: An Open-Source Tool for Deep Learning-Based Atherosclerotic Plaque Quantification in Histopathology Image.https://mml.kite.ume.de/publications/murray-vesseg-2021/Fri, 01 Oct 2021 00:00:00 +0000https://mml.kite.ume.de/publications/murray-vesseg-2021/Joint Imaging Platform for Federated Clinical Data Analyticshttps://mml.kite.ume.de/publications/scherer-joint-2020/Sun, 01 Nov 2020 00:00:00 +0000https://mml.kite.ume.de/publications/scherer-joint-2020/PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysishttps://mml.kite.ume.de/publications/seifert-psma-2020/Tue, 01 Sep 2020 00:00:00 +0000https://mml.kite.ume.de/publications/seifert-psma-2020/Semi-automatically quantified tumor volume using Ga-68-PSMA-11-PET as biomarker for survival in patients with advanced prostate cancerhttps://mml.kite.ume.de/publications/seifert-semi-automatically-2020/Wed, 01 Apr 2020 00:00:00 +0000https://mml.kite.ume.de/publications/seifert-semi-automatically-2020/Künstliche Intelligenz in der Hybridbildgebunghttps://mml.kite.ume.de/publications/strack-kunstliche-2020/Sat, 01 Feb 2020 00:00:00 +0000https://mml.kite.ume.de/publications/strack-kunstliche-2020/Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving $^textrm177$ Lu-PSMA-617 Radioligand Therapyhttps://mml.kite.ume.de/publications/seifert-analysis-2020/Wed, 01 Jan 2020 00:00:00 +0000https://mml.kite.ume.de/publications/seifert-analysis-2020/